title: Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study.
authors.affiliation: Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA. awessels@iupui.edu
authors.forename: Alette M
authors.initials: AM
authors.lastname: Wessels
authors.forename: Robert R
authors.initials: RR
authors.lastname: Bies
authors.forename: Bruce G
authors.initials: BG
authors.lastname: Pollock
authors.forename: Lon S
authors.initials: LS
authors.lastname: Schneider
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Lieberman
authors.forename: Scott
authors.initials: S
authors.lastname: Stroup
authors.forename: Claire H
authors.initials: CH
authors.lastname: Li
authors.forename: Kim
authors.initials: K
authors.lastname: Coley
authors.forename: Margaret M
authors.initials: MM
authors.lastname: Kirshner
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Marder
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D013844:Thiazoles / Q000493:pharmacokinetics* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone